南山北
2017-09-28
$雅培(ABT)$ 什么状况?大跌,盘后又大涨?
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
南山北
2017-09-28
南山北
雅培(NYSE: ABT)+ 3.5% 啊的消息,FDA批准其自由泳自由闪光的血糖监测装置为血糖监测对糖尿病患者置换。
批准意味着~ 3000万人在美国糖尿病现在可以追踪他们的血糖水平,而不需要刺破自己的手指。
ABT生根粉的装置使用戴在上臂的后面连续测量和监测血糖水平达10天,一个小的传感器,使其持续时间最长的个人的葡萄糖传感器在美国
血糖监测系统为主的公司(纳斯达克股票代码:公司提供dx
南山北
2017-09-28
南山北
原来这样。
什么也没有了~
APP内打开
发表看法
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":98782,"tweetId":"98782","gmtCreate":1506557012827,"gmtModify":1704881681699,"author":{"id":3463977920804261,"idStr":"3463977920804261","authorId":3463977920804261,"authorIdStr":"3463977920804261","name":"南山北","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$雅培(ABT)$ 什么状况?大跌,盘后又大涨?</p></body></html>","htmlText":"<html><head></head><body><p>$雅培(ABT)$ 什么状况?大跌,盘后又大涨?</p></body></html>","text":"$雅培(ABT)$ 什么状况?大跌,盘后又大涨?","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/98782","repostId":0,"isVote":1,"tweetType":1,"viewCount":2104,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ABT"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":36,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":454547,"commentId":"454547","gmtCreate":1506557168127,"gmtModify":1506557168127,"authorId":3463977920804261,"author":{"id":3463977920804261,"idStr":"3463977920804261","authorId":3463977920804261,"name":"南山北","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":98782,"objectIdStr":"98782","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"雅培(NYSE: ABT)+ 3.5% 啊的消息,FDA批准其自由泳自由闪光的血糖监测装置为血糖监测对糖尿病患者置换。\n<br>\n<br>批准意味着~ 3000万人在美国糖尿病现在可以追踪他们的血糖水平,而不需要刺破自己的手指。\n<br>\n<br>ABT生根粉的装置使用戴在上臂的后面连续测量和监测血糖水平达10天,一个小的传感器,使其持续时间最长的个人的葡萄糖传感器在美国\n<br>\n<br>血糖监测系统为主的公司(纳斯达克股票代码:公司提供dx","text":"雅培(NYSE: ABT)+ 3.5% 啊的消息,FDA批准其自由泳自由闪光的血糖监测装置为血糖监测对糖尿病患者置换。\n<br>\n<br>批准意味着~ 3000万人在美国糖尿病现在可以追踪他们的血糖水平,而不需要刺破自己的手指。\n<br>\n<br>ABT生根粉的装置使用戴在上臂的后面连续测量和监测血糖水平达10天,一个小的传感器,使其持续时间最长的个人的葡萄糖传感器在美国\n<br>\n<br>血糖监测系统为主的公司(纳斯达克股票代码:公司提供dx","html":"雅培(NYSE: ABT)+ 3.5% 啊的消息,FDA批准其自由泳自由闪光的血糖监测装置为血糖监测对糖尿病患者置换。\n<br>\n<br>批准意味着~ 3000万人在美国糖尿病现在可以追踪他们的血糖水平,而不需要刺破自己的手指。\n<br>\n<br>ABT生根粉的装置使用戴在上臂的后面连续测量和监测血糖水平达10天,一个小的传感器,使其持续时间最长的个人的葡萄糖传感器在美国\n<br>\n<br>血糖监测系统为主的公司(纳斯达克股票代码:公司提供dx","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":454548,"commentId":"454548","gmtCreate":1506557198677,"gmtModify":1506557198677,"authorId":3463977920804261,"author":{"id":3463977920804261,"idStr":"3463977920804261","authorId":3463977920804261,"name":"南山北","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":98782,"objectIdStr":"98782","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"原来这样。","text":"原来这样。","html":"原来这样。","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/98782"}
精彩评论
批准意味着~ 3000万人在美国糖尿病现在可以追踪他们的血糖水平,而不需要刺破自己的手指。
ABT生根粉的装置使用戴在上臂的后面连续测量和监测血糖水平达10天,一个小的传感器,使其持续时间最长的个人的葡萄糖传感器在美国
血糖监测系统为主的公司(纳斯达克股票代码:公司提供dx